Strategic collaboration between Genencor and Brain

Genencor (Palo Alto, Calif.; www.genencor.com), a division of Danisco A/S (Copenhagen, Denmark; www.danisco.com) and Brain AG (Zwingenberg, Germany; www.brain-biotech.de), have joined forces in the field of the bio-based fermentative production of industrially relevant biochemicals from renewable raw materials. Genencor will use its extensive capabilities in metabolic pathway engineering and bio-manufacturing of industrial bio-products and Brain AG’s world leading expertise in the fields of metagenomics and screening technologies, to pursue product targets for the chemical industry. Brain will provide Genencor access to these technologies and especially to its vast metagenome resources of some150 million genes of yet uncultured microorganisms. Enzymes and biosynthetic pathways of interest will then be genetically engineered in microbial production strains for the production of important biochemicals. This new collaboration announced today expands upon the successful collaboration first established in 2004, where the two companies joined forces to develop a new enzyme product platform.   For Brain, the collaboration is also an important milestone in the company’s strategy of further expanding its strategic partnerships…